| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2006-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7908cc4e68505f343d14b8e224f53d03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8577ca2208d8dbd7de815fb7ce302130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0afdf30f08d152781efa34e7197036 |
| publicationDate |
2011-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0619476-A2 |
| titleOfInvention |
Interleukin-11 compositions and methods of use |
| abstract |
COMPOSITIONS OF INTERLEUCIN-11 AND METHODS OF USE. The present invention relates to methods for the treatment and / or prevention of thrombocytopenia including thrombocytopenia associated with drug-induced liver injury thrombocytopenia associated with drug-induced bone marrow destruction. Treatment methods of the invention include administering interleukin-11 to an individual suffering from or being susceptible to thrombocytopenia and / or receiving or about to receive treatment involving a conjugated therapeutic agent whose administration results in thrombocytopenia. Pharmaceutical compositions and kits useful for carrying out these treatment methods are also provided. |
| priorityDate |
2005-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |